ATE178065T1 - Kondensierte imidazol- und triazolderivate als 5- hta rezeptoragonisten - Google Patents

Kondensierte imidazol- und triazolderivate als 5- hta rezeptoragonisten

Info

Publication number
ATE178065T1
ATE178065T1 AT93911925T AT93911925T ATE178065T1 AT E178065 T1 ATE178065 T1 AT E178065T1 AT 93911925 T AT93911925 T AT 93911925T AT 93911925 T AT93911925 T AT 93911925T AT E178065 T1 ATE178065 T1 AT E178065T1
Authority
AT
Austria
Prior art keywords
pct
receptor agonists
triazole derivatives
condensed imidazole
date nov
Prior art date
Application number
AT93911925T
Other languages
English (en)
Inventor
Leslie Joseph Spruce Street
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Application granted granted Critical
Publication of ATE178065T1 publication Critical patent/ATE178065T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
AT93911925T 1992-05-15 1993-05-06 Kondensierte imidazol- und triazolderivate als 5- hta rezeptoragonisten ATE178065T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929210400A GB9210400D0 (en) 1992-05-15 1992-05-15 Therapeutic agents

Publications (1)

Publication Number Publication Date
ATE178065T1 true ATE178065T1 (de) 1999-04-15

Family

ID=10715527

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93911925T ATE178065T1 (de) 1992-05-15 1993-05-06 Kondensierte imidazol- und triazolderivate als 5- hta rezeptoragonisten

Country Status (10)

Country Link
US (1) US5514682A (de)
EP (1) EP0640085B1 (de)
JP (1) JP3283260B2 (de)
AT (1) ATE178065T1 (de)
AU (1) AU671836B2 (de)
CA (1) CA2134986A1 (de)
DE (1) DE69324140T2 (de)
ES (1) ES2128427T3 (de)
GB (1) GB9210400D0 (de)
WO (1) WO1993023396A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5559246A (en) * 1990-10-15 1996-09-24 Pfizer Inc. Indole derivatives
US5607951A (en) * 1990-10-15 1997-03-04 Pfizer Inc Indole derivatives
US5559129A (en) * 1990-10-15 1996-09-24 Pfizer Inc Indole derivatives
US5578612A (en) * 1990-10-15 1996-11-26 Pfizer Inc. Indole derivatives
US5545644A (en) * 1990-10-15 1996-08-13 Pfizer Inc. Indole derivatives
TW251284B (de) * 1992-11-02 1995-07-11 Pfizer
AU686654B2 (en) * 1993-08-31 1998-02-12 Pfizer Inc. 5-arylindole derivatives
NZ276172A (en) * 1994-02-10 1998-02-26 Pfizer 5-heteroarylindole derivatives as benzodiazepine receptor site agonists and antagonists, 5-(hetero)arylaminoindole intermediates
GB9417310D0 (en) 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents
US5484763A (en) * 1995-02-10 1996-01-16 American Cyanamid Company Substituted benzisoxazole and benzisothiazole herbicidal agents
JP2002507996A (ja) 1997-07-03 2002-03-12 デュポン ファーマシューティカルズ カンパニー 神経学的障害を治療するためのイミダゾピリミジン類およびイミダゾピリジン類
US6162804A (en) * 1997-09-26 2000-12-19 Merck & Co., Inc. Tyrosine kinase inhibitors
US6465484B1 (en) * 1997-09-26 2002-10-15 Merck & Co., Inc. Angiogenesis inhibitors
US6365589B1 (en) 1998-07-02 2002-04-02 Bristol-Myers Squibb Pharma Company Imidazo-pyridines, -pyridazines, and -triazines as corticotropin releasing factor antagonists
US6124463A (en) * 1998-07-02 2000-09-26 Dupont Pharmaceuticals Benzimidazoles as corticotropin release factor antagonists
CA2341409A1 (en) * 1998-08-31 2000-03-09 Merck And Co., Inc. Novel angiogenesis inhibitors
US5994352A (en) * 1998-11-13 1999-11-30 Pfizer Inc. 5-arylindole derivatives
BR0312175A (pt) 2002-06-21 2005-04-05 Suven Life Sciences Ltd Composto, composição farmacêutica, uso de um composto, método para o tratamento e método para reduzir a morbidez e a mortalidade associadas com o excesso de peso
ES2297216T3 (es) 2002-06-21 2008-05-01 Suven Life Sciences Limited Indoles tetraciclicos arilsulfonil que tienen afinidad con el receptor de la serotonina.
US7507835B2 (en) 2002-11-28 2009-03-24 Suven Life Sciences Ltd. N-arylsulfonyl-3-aminoalkoxyindoles
ATE401307T1 (de) 2002-11-28 2008-08-15 Suven Life Sciences Ltd N-arylsulfonyl-2-substituierte indole mit affinität zum serotonin rezeptor, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen
JP4571507B2 (ja) 2002-12-18 2010-10-27 スベン ライフ サイエンシズ リミティド セロトニン受容体親和性を有する四環系3−置換インドール
EP1724271A4 (de) * 2004-02-26 2013-01-23 Kyowa Hakko Kirin Co Ltd Präventives und/oder therapeutisches mittel gegen neutrophile entzündungskrankheit
KR101594002B1 (ko) 2010-10-06 2016-02-15 글락소스미스클라인 엘엘씨 Pi3 키나제 억제제로서의 벤즈이미다졸 유도체
BR122023023802A2 (pt) * 2015-04-29 2023-12-26 Janssen Pharmaceutica Nv Compostos azabenzimidazóis, seu uso como moduladores do receptor de ampa e composições farmacêuticas que os compreendem

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE58370B1 (en) * 1985-04-10 1993-09-08 Lundbeck & Co As H Indole derivatives
GB8724912D0 (en) * 1987-10-23 1987-11-25 Wellcome Found Indole derivatives
HU225055B1 (en) * 1990-10-15 2006-05-29 Pfizer Indole derivatives, their intermediates, process for production them and pharmaceutical compositions containing the compounds
CZ283018B6 (cs) * 1991-02-01 1997-12-17 Merck Sharp And Dohme Limited Deriváty imidazolu, triazolu a tetrazolu a farmaceutické přípravky na jejich bázi
TW251284B (de) * 1992-11-02 1995-07-11 Pfizer

Also Published As

Publication number Publication date
WO1993023396A1 (en) 1993-11-25
EP0640085B1 (de) 1999-03-24
JP3283260B2 (ja) 2002-05-20
AU671836B2 (en) 1996-09-12
EP0640085A1 (de) 1995-03-01
AU4269793A (en) 1993-12-13
ES2128427T3 (es) 1999-05-16
US5514682A (en) 1996-05-07
DE69324140T2 (de) 1999-10-28
JPH07506825A (ja) 1995-07-27
DE69324140D1 (de) 1999-04-29
GB9210400D0 (en) 1992-07-01
CA2134986A1 (en) 1993-11-25

Similar Documents

Publication Publication Date Title
DE69324140D1 (de) Kondensierte imidazol- und triazolderivate als 5-hta rezeptoragonisten
ATE205202T1 (de) Imidazol-, triazol- und tetrazolderivate
ATE144773T1 (de) Indol-derivate als 5-ht1-ähnliche antagonisten zur behandlung von migräne
DE69331190D1 (de) Überbrückte azabicyclische derivate als substanz p antagonisten
ES2121193T3 (es) Derivados de bencimidazoles.
ATE183504T1 (de) Piperazinderivate als 5-ht rezeptor antagonisten
ATE171445T1 (de) Perhydroisoindolderivate als substanz p antagonisten
HU9300618D0 (en) Imidazole derivatives containing biphenyl-sulfonyl-urea side chain or biphenyl-sulfonyl-urethane one as well as method for producing them and their utilization
ATE250598T1 (de) 5-(2-imidazolinylamino)benzimidazol derivate, deren herstellung und deren verwendung als alpha- 2-adrenoceptor agonisten
DE59510635D1 (de) Verwendung heterocyclischer verbindungen als dopamin-d 3 liganden
BR9910621A (pt) Novos compostos de imidazol 2-alquil substituìdos
CO4950530A1 (es) Agonistas de receptores 5-ht, y metoclopramida para el tratamiento de la migrana
DE69419917D1 (de) Indazolderivate
ATE177096T1 (de) 4-substituierte 1,2,4-triazolderivate
DE69301357D1 (de) Indol derivate als "5-ht1-like" agonisten
DE69329645D1 (de) Imidazol-, triazol- und tetrazolderivate
ATE164376T1 (de) Indol derivate als steroid 5 alpha-reductase inhibitoren
DK0823909T3 (da) Hidtil ukendte heterocykliske forbindelser
NO952427D0 (no) Metode for behandling av kronisk prostatitt med 17 substituerte karbamoyl-4-aza-5
MY108739A (en) Imidazole, triazole and tetrazole derivatives
KR970042548A (ko) 이미다조 피리딘 유도체,이의 제조방법 및 이를 함유한 약제학적 조성물

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties